The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.

Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...

Gastrointestinal stromal tumors (GISTs) represent a rare tumor entity that occurs in the muscular layer of the digestive tract. These tumors commonly metastasize to the liver and peritoneum ...

Other, less common, types of stomach cancer are: Gastro-intestinal stromal tumours (GISTs), which develop in the stomach wall Neuroendocrine tumours (NETs), which start in the stomach’s hormone ...

Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less ...

Gastric cancer, commonly known as stomach cancer ... potentially eradicating the need for aggressive therapies. Gastrointestinal Stromal Tumours (GISTs) GIST is a rare tumour that arises in ...

Management trends and outcomes of appendiceal cancers: A National Cancer Database study. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not ...

The deal, which includes another $150 million in milestone payments, gives GSK an experimental treatment for a rare gastrointestinal cancer. The announcement comes as much of the biopharma world ...

The British pharma giant plans to shell out $1 billion upfront to buy the drug developer working on a lead treatment for gastrointestinal stromal tumors. As the first morning of the J.P. Morgan ...